ACE-1 enzyme activity is elevated in the temporal cortex at early/intermediate stages of Alzheimer's disease (Braak stage III-IV) compared to Braak stage 0-II, independent of age-related changes.
Observational (n=181)
Yes
ACE-1 activity is induced in the early stages of Alzheimer's disease independently of normal physiological age-related changes in ACE-1 protein.
An imbalance in the renin-angiotensin system (RAS) is associated with cognitive decline and disease pathology in Alzheimer's disease (AD). In this study, we have investigated changes in the brain angiotensin-converting enzyme-1 (ACE-1) and angiotensin-II (Ang-II), and the counter-regulatory angiotensin-converting enzyme-2 (ACE-2), in the frontal and temporal cortex during normal aging and in the early stages of AD. We studied a cohort of normal aging (n = 121; 19-95 years age-at-death) from the Sudden Death Brain Bank, University of Edinburgh, United Kingdom, and AD and age-matched controls (n = 60) from the South West Dementia Brain Bank, University of Bristol, United Kingdom, stratified according to Braak tangle stage (BS): 0-II, III-IV (intermediate disease), and V-VI (end-stage disease). ACE-1 and ACE-2 enzyme activity were measured using fluorogenic peptide activity assays. ACE-1, ACE-2, and Ang-II protein level were measured by enzyme-linked immunosorbent assay (ELISA). In both regions, ACE-1 protein and Ang-II levels correlated positively with age whereas ACE-1 enzyme activity was inversely related to age. ACE-1 protein correlated positively with Ang-II, whilst ACE-1 activity correlated inversely with Ang-II in normal aging. ACE-1 enzyme activity was elevated at an early/intermediate stage, BS III-IV compared to BS 0-II in the temporal cortex in AD. ACE-2 protein and enzyme activity were unchanged with aging and in AD. In conclusion, ACE-1 activity is induced in the early stages of AD independently from normal physiological age-related changes in ACE-1 protein.
MacLachlan et al. (Sat,) conducted a observational in Alzheimer's disease and normal aging (n=181). Alzheimer's disease pathology (Braak stage III-IV) vs. Braak stage 0-II was evaluated on ACE-1 and ACE-2 enzyme activity and protein levels, and Ang-II protein levels in the frontal and temporal cortex. ACE-1 enzyme activity is elevated in the temporal cortex at early/intermediate stages of Alzheimer's disease (Braak stage III-IV) compared to Braak stage 0-II, independent of age-related changes.